|
2025-03-04 |
2025-03-04 |
S
Sale
|
Clark Eliana
EVP, Chief Technical Officer
Officer
|
679
-0.7%
8.99
USD 6,104
|
679
-0.7%
|
8.99
|
USD 6,104
|
|
|
2025-03-04 |
2025-03-04 |
S
Sale
|
BASTA JAMES
EVP, General Counsel
Officer
|
2,572
-2.2%
8.99
USD 23,122
|
2,572
-2.2%
|
8.99
|
USD 23,122
|
|
|
2025-01-31 |
2025-01-29 |
PS
Planned sale
|
Bhanji Muna
Non-Executive Director
|
265
-1.3%
9.97
USD 2,642
|
265
-1.3%
|
9.97
|
USD 2,642
|
|
|
2025-01-07 |
2025-01-03 |
S
Sale
|
Dube Michael P
VP, Chief Accounting Officer
Officer
|
1,372
-2.9%
12.18
USD 16,711
|
1,372
-2.9%
|
12.18
|
USD 16,711
|
|
|
2025-01-07 |
2025-01-03 |
S
Sale
|
Hicks Derek
EVP, Chief Business Officer
Officer
|
6,502
-9.8%
12.18
USD 79,194
|
6,502
-9.8%
|
12.18
|
USD 79,194
|
|
|
2025-01-07 |
2025-01-03 |
S
Sale
|
LEONARD JOHN M
President and CEO
Executive Director
|
26,807
-2.8%
12.18
USD 326,509
|
26,807
-2.8%
|
12.18
|
USD 326,509
|
|
|
2025-01-07 |
2025-01-03 |
S
Sale
|
BASTA JAMES
EVP, General Counsel
Officer
|
7,074
-8.7%
12.18
USD 86,161
|
7,074
-8.7%
|
12.18
|
USD 86,161
|
|
|
2025-01-07 |
2025-01-03 |
S
Sale
|
Lebwohl David
EVP, Chief Medical Officer
Officer
|
9,557
-9.8%
12.18
USD 116,404
|
9,557
-9.8%
|
12.18
|
USD 116,404
|
|
|
2025-01-07 |
2025-01-03 |
S
Sale
|
Sepp-Lorenzino Laura
EVP, Chief Scientific Officer
Officer
|
8,966
-10.4%
12.18
USD 109,206
|
8,966
-10.4%
|
12.18
|
USD 109,206
|
|
|
2025-01-06 |
2025-01-03 |
S
Sale
|
Clark Eliana
EVP, Chief Technical Officer
Officer
|
7,422
-10.4%
12.18
USD 90,400
|
7,422
-10.4%
|
12.18
|
USD 90,400
|
|
|
2025-01-06 |
2025-01-02 |
PS
Planned sale
|
Clark Eliana
EVP, Chief Technical Officer
Officer
|
556
-0.8%
12.03
USD 6,689
|
556
-0.8%
|
12.03
|
USD 6,689
|
|
|
2024-10-04 |
2024-10-02 |
S
Sale
|
Dube Michael P
VP, Chief Accounting Officer
Officer
|
2,012
-4.1%
19.01
USD 38,248
|
2,012
-4.1%
|
19.01
|
USD 38,248
|
|
|
2024-07-03 |
2024-07-01 |
PS
Planned sale
|
Clark Eliana
EVP, Chief Technical Officer
Officer
|
405
-0.6%
22.93
USD 9,287
|
405
-0.6%
|
22.93
|
USD 9,287
|
|
|
2024-06-20 |
2024-06-17 |
PS
Planned sale
|
Verwiel Frank
Non-Executive Director
|
1,505
-7.7%
25.00
USD 37,625
|
1,505
-7.7%
|
25.00
|
USD 37,625
|
|
|
2024-03-05 |
2024-03-04 |
S
Sale
|
BASTA JAMES
EVP, General Counsel
Officer
|
2,297
-2.7%
32.99
USD 75,778
|
2,297
-2.7%
|
32.99
|
USD 75,778
|
|
|
2024-03-05 |
2024-03-04 |
S
Sale
|
Clark Eliana
EVP, Chief Technical Officer
Officer
|
605
-0.8%
32.99
USD 19,959
|
605
-0.8%
|
32.99
|
USD 19,959
|
|
|
2024-01-10 |
2024-01-08 |
PS
Planned sale
|
Sepp-Lorenzino Laura
EVP, Chief Scientific Officer
Officer
|
667
-1.5%
29.38
USD 19,596
|
667
-1.5%
|
29.38
|
USD 19,596
|
|
|
2024-01-10 |
2024-01-08 |
PS
Planned sale
|
Sepp-Lorenzino Laura
EVP, Chief Scientific Officer
Officer
|
1,608
-3.5%
28.66
USD 46,085
|
1,608
-3.5%
|
28.66
|
USD 46,085
|
|
|
2024-01-05 |
2024-01-03 |
S
Sale
|
Goddard Glenn
EVP, Chief Financial Officer
Officer
|
5,365
-11.7%
29.46
USD 158,053
|
5,365
-11.7%
|
29.46
|
USD 158,053
|
|
|
2024-01-05 |
2024-01-03 |
S
Sale
|
Hicks Derek
EVP, Chief Business Officer
Officer
|
3,877
-9.5%
29.46
USD 114,216
|
3,877
-9.5%
|
29.46
|
USD 114,216
|
|
|
2024-01-05 |
2024-01-03 |
S
Sale
|
Sepp-Lorenzino Laura
EVP, Chief Scientific Officer
Officer
|
5,532
-10.7%
29.46
USD 162,973
|
5,532
-10.7%
|
29.46
|
USD 162,973
|
|
|
2024-01-05 |
2024-01-03 |
S
Sale
|
LEONARD JOHN M
President and CEO
Executive Director
|
19,223
-2.2%
29.46
USD 566,310
|
19,223
-2.2%
|
29.46
|
USD 566,310
|
|
|
2024-01-05 |
2024-01-03 |
S
Sale
|
Clark Eliana
EVP, Chief Technical Officer
Officer
|
4,301
-9.5%
29.46
USD 126,707
|
4,301
-9.5%
|
29.46
|
USD 126,707
|
|
|
2024-01-05 |
2024-01-03 |
PS
Planned sale
|
Clark Eliana
EVP, Chief Technical Officer
Officer
|
307
-0.7%
30.12
USD 9,247
|
307
-0.7%
|
30.12
|
USD 9,247
|
|
|
2024-01-05 |
2024-01-03 |
S
Sale
|
Lebwohl David
EVP, Chief Medical Officer
Officer
|
5,843
-9.7%
29.46
USD 172,135
|
5,843
-9.7%
|
29.46
|
USD 172,135
|
|
|
2024-01-05 |
2024-01-03 |
S
Sale
|
BASTA JAMES
EVP, General Counsel
Officer
|
3,805
-6.9%
29.46
USD 112,095
|
3,805
-6.9%
|
29.46
|
USD 112,095
|
|
|
2023-11-02 |
2023-10-31 |
PS
Planned sale
|
Bhanji Muna
Non-Executive Director
|
265
-2.2%
23.90
USD 6,334
|
265
-2.2%
|
23.90
|
USD 6,334
|
|
|
2023-08-02 |
2023-07-31 |
PS
Planned sale
|
Bhanji Muna
Non-Executive Director
|
265
-2.1%
42.33
USD 11,217
|
265
-2.1%
|
42.33
|
USD 11,217
|
|
|
2023-07-10 |
2023-07-06 |
PS
Planned sale
|
Bhanji Muna
Non-Executive Director
|
1,867
-13.0%
39.30
USD 73,373
|
1,867
-13.0%
|
39.30
|
USD 73,373
|
|
|
2023-07-06 |
2023-07-03 |
PS
Planned sale
|
Clark Eliana
EVP, Chief Technical Officer
Officer
|
360
-0.8%
40.51
USD 14,584
|
360
-0.8%
|
40.51
|
USD 14,584
|
|
|
2023-06-22 |
2023-06-20 |
PS
Planned sale
|
Clark Eliana
EVP, Chief Technical Officer
Officer
|
5,000
-10.0%
45.00
USD 225,000
|
5,000
-10.0%
|
45.00
|
USD 225,000
|
|
|
2023-03-03 |
2023-03-02 |
S
Sale
|
BASTA JAMES
EVP, General Counsel
Officer
|
1,088
-1.9%
43.88
USD 47,741
|
1,088
-1.9%
|
43.88
|
USD 47,741
|
|
|
2023-01-06 |
2023-01-05 |
PS
Planned sale
|
Sepp-Lorenzino Laura
EVP, Chief Scientific Officer
Officer
|
689
-3.8%
39.10
USD 26,940
|
689
-3.8%
|
39.10
|
USD 26,940
|
|
|
2023-01-06 |
2023-01-05 |
PS
Planned sale
|
Sepp-Lorenzino Laura
EVP, Chief Scientific Officer
Officer
|
1,641
-8.2%
38.22
USD 62,719
|
1,641
-8.2%
|
38.22
|
USD 62,719
|
|
|
2023-01-06 |
2023-01-04 |
S
Sale
|
Hicks Derek
EVP, Chief Business Officer
Officer
|
1,812
-9.5%
37.21
USD 67,425
|
1,812
-9.5%
|
37.21
|
USD 67,425
|
|
|
2023-01-06 |
2023-01-04 |
S
Sale
|
Lebwohl David
EVP, Chief Medical Officer
Officer
|
2,574
-9.1%
37.21
USD 95,779
|
2,574
-9.1%
|
37.21
|
USD 95,779
|
|
|
2023-01-06 |
2023-01-04 |
S
Sale
|
BASTA JAMES
EVP, General Counsel
Officer
|
1,138
-5.5%
37.21
USD 42,345
|
1,138
-5.5%
|
37.21
|
USD 42,345
|
|
|
2023-01-06 |
2023-01-04 |
S
Sale
|
LEONARD JOHN M
President and CEO
Executive Director
|
6,673
-0.9%
37.21
USD 248,302
|
6,673
-0.9%
|
37.21
|
USD 248,302
|
|
|
2023-01-06 |
2023-01-04 |
S
Sale
|
Sepp-Lorenzino Laura
EVP, Chief Scientific Officer
Officer
|
2,508
-11.2%
37.21
USD 93,323
|
2,508
-11.2%
|
37.21
|
USD 93,323
|
|
|
2023-01-06 |
2023-01-04 |
S
Sale
|
Clark Eliana
EVP, Chief Technical Officer
Officer
|
1,692
-10.5%
37.21
USD 62,959
|
1,692
-10.5%
|
37.21
|
USD 62,959
|
|
|
2023-01-06 |
2023-01-04 |
S
Sale
|
Goddard Glenn
EVP, Chief Financial Officer
Officer
|
2,427
-13.6%
37.21
USD 90,309
|
2,427
-13.6%
|
37.21
|
USD 90,309
|
|
|
2023-01-06 |
2023-01-03 |
PS
Planned sale
|
Clark Eliana
EVP, Chief Technical Officer
Officer
|
231
-1.4%
34.48
USD 7,965
|
231
-1.4%
|
34.48
|
USD 7,965
|
|
|
2023-01-06 |
2022-07-01 |
PS
Planned sale
|
Clark Eliana
EVP, Chief Technical Officer
Officer
|
105
-0.6%
51.74
USD 5,433
|
105
-0.6%
|
51.74
|
USD 5,433
|
|
|
2022-03-04 |
2022-01-01 |
S
Sale
|
LEONARD JOHN M
President and CEO
Executive Director
|
2,493
-0.3%
112.26
USD 279,852
|
2,493
-0.3%
|
112.26
|
USD 279,852
|
|
|
2022-03-03 |
2022-01-01 |
S
Sale
|
Sepp-Lorenzino Laura
EVP, Chief Scientific Officer
Officer
|
1,148
-19.3%
112.25
USD 128,863
|
1,148
-19.3%
|
112.25
|
USD 128,863
|
|
|
2022-03-03 |
2022-01-01 |
S
Sale
|
Lebwohl David
EVP, Chief Medical Officer
Officer
|
1,051
-8.8%
112.24
USD 117,964
|
1,051
-8.8%
|
112.24
|
USD 117,964
|
|
|
2022-03-03 |
2022-01-01 |
S
Sale
|
Goddard Glenn
EVP, Chief Financial Officer
Officer
|
1,013
-33.1%
112.24
USD 113,699
|
1,013
-33.1%
|
112.24
|
USD 113,699
|
|
|
2021-11-09 |
2021-11-05 |
PS
Planned sale
|
Lebwohl David
EVP, Chief Medical Officer
Officer
|
200
-2.2%
135.34
USD 27,068
|
200
-2.2%
|
135.34
|
USD 27,068
|
|
|
2021-11-09 |
2021-11-05 |
PS
Planned sale
|
Lebwohl David
EVP, Chief Medical Officer
Officer
|
548
-5.8%
134.07
USD 73,470
|
548
-5.8%
|
134.07
|
USD 73,470
|
|
|
2021-11-09 |
2021-11-05 |
PS
Planned sale
|
Lebwohl David
EVP, Chief Medical Officer
Officer
|
452
-4.6%
132.62
USD 59,944
|
452
-4.6%
|
132.62
|
USD 59,944
|
|
|
2021-11-09 |
2021-11-05 |
PS
Planned sale
|
Lebwohl David
EVP, Chief Medical Officer
Officer
|
1,200
-10.8%
131.71
USD 158,052
|
1,200
-10.8%
|
131.71
|
USD 158,052
|
|
|
2021-10-15 |
2021-10-14 |
PS
Planned sale
|
Lebwohl David
EVP, Chief Medical Officer
Officer
|
250
-2.8%
130.47
USD 32,618
|
250
-2.8%
|
130.47
|
USD 32,618
|
|
|
2021-10-15 |
2021-10-14 |
PS
Planned sale
|
Lebwohl David
EVP, Chief Medical Officer
Officer
|
525
-5.5%
129.83
USD 68,161
|
525
-5.5%
|
129.83
|
USD 68,161
|
|
|
2021-10-15 |
2021-10-14 |
PS
Planned sale
|
Lebwohl David
EVP, Chief Medical Officer
Officer
|
225
-2.3%
129.01
USD 29,027
|
225
-2.3%
|
129.01
|
USD 29,027
|
|
|
2021-10-15 |
2021-10-14 |
PS
Planned sale
|
Lebwohl David
EVP, Chief Medical Officer
Officer
|
849
-8.0%
127.81
USD 108,511
|
849
-8.0%
|
127.81
|
USD 108,511
|
|
|
2021-10-15 |
2021-10-14 |
PS
Planned sale
|
Lebwohl David
EVP, Chief Medical Officer
Officer
|
551
-5.0%
126.92
USD 69,933
|
551
-5.0%
|
126.92
|
USD 69,933
|
|
|
2021-10-13 |
2021-10-11 |
PS
Planned sale
|
Crowley John F
Non-Executive Director
|
2,500
-54.4%
119.55
USD 298,875
|
2,500
-54.4%
|
119.55
|
USD 298,875
|
|
|
2021-10-07 |
2021-10-05 |
PS
Planned sale
|
Crowley John F
Non-Executive Director
|
200
-8.7%
132.84
USD 26,568
|
200
-8.7%
|
132.84
|
USD 26,568
|
|
|
2021-10-07 |
2021-10-05 |
PS
Planned sale
|
Crowley John F
Non-Executive Director
|
1,846
-44.6%
131.74
USD 243,192
|
1,846
-44.6%
|
131.74
|
USD 243,192
|
|
|
2021-10-07 |
2021-10-05 |
PS
Planned sale
|
Crowley John F
Non-Executive Director
|
3,759
-47.6%
130.92
USD 492,128
|
3,759
-47.6%
|
130.92
|
USD 492,128
|
|
|
2021-10-07 |
2021-10-05 |
PS
Planned sale
|
Crowley John F
Non-Executive Director
|
2,915
-27.0%
129.88
USD 378,600
|
2,915
-27.0%
|
129.88
|
USD 378,600
|
|
|
2021-10-07 |
2021-10-05 |
PS
Planned sale
|
Crowley John F
Non-Executive Director
|
1,280
-10.6%
128.83
USD 164,902
|
1,280
-10.6%
|
128.83
|
USD 164,902
|
|
|
2021-09-01 |
2021-09-01 |
PS
Planned sale
|
LEONARD JOHN M
President and CEO
Executive Director
|
44,735
-5.9%
170.00
USD 7,604,950
|
44,735
-5.9%
|
170.00
|
USD 7,604,950
|
|
|
2021-09-01 |
2021-08-31 |
PS
Planned sale
|
LEONARD JOHN M
President and CEO
Executive Director
|
37,833
-5.0%
155.00
USD 5,864,115
|
37,833
-5.0%
|
155.00
|
USD 5,864,115
|
|
|
2021-09-01 |
2021-08-31 |
PS
Planned sale
|
Goddard Glenn
EVP, Chief Financial Officer
Officer
|
24,800
-100.0%
160.22
USD 3,973,456
|
24,800
-100.0%
|
160.22
|
USD 3,973,456
|
|
|
2021-09-01 |
2021-08-30 |
PS
Planned sale
|
LEONARD JOHN M
President and CEO
Executive Director
|
216
-0.0%
160.69
USD 34,709
|
216
-0.0%
|
160.69
|
USD 34,709
|
|
|
2021-09-01 |
2021-08-30 |
PS
Planned sale
|
LEONARD JOHN M
President and CEO
Executive Director
|
725
-0.1%
159.98
USD 115,986
|
725
-0.1%
|
159.98
|
USD 115,986
|
|
|
2021-09-01 |
2021-08-30 |
PS
Planned sale
|
LEONARD JOHN M
President and CEO
Executive Director
|
2,598
-0.4%
159.18
USD 413,550
|
2,598
-0.4%
|
159.18
|
USD 413,550
|
|
|
2021-09-01 |
2021-08-30 |
PS
Planned sale
|
LEONARD JOHN M
President and CEO
Executive Director
|
3,123
-0.4%
157.75
USD 492,653
|
3,123
-0.4%
|
157.75
|
USD 492,653
|
|
|
2021-09-01 |
2021-08-30 |
PS
Planned sale
|
LEONARD JOHN M
President and CEO
Executive Director
|
4,758
-0.7%
156.96
USD 746,816
|
4,758
-0.7%
|
156.96
|
USD 746,816
|
|
|
2021-09-01 |
2021-08-30 |
PS
Planned sale
|
LEONARD JOHN M
President and CEO
Executive Director
|
15,567
-2.1%
155.70
USD 2,423,782
|
15,567
-2.1%
|
155.70
|
USD 2,423,782
|
|
|
2021-09-01 |
2021-08-30 |
PS
Planned sale
|
LEONARD JOHN M
President and CEO
Executive Director
|
7,428
-1.0%
154.98
USD 1,151,191
|
7,428
-1.0%
|
154.98
|
USD 1,151,191
|
|
|
2021-09-01 |
2021-08-30 |
PS
Planned sale
|
LEONARD JOHN M
President and CEO
Executive Director
|
2,334
-0.3%
153.66
USD 358,642
|
2,334
-0.3%
|
153.66
|
USD 358,642
|
|
|
2021-09-01 |
2021-08-30 |
PS
Planned sale
|
LEONARD JOHN M
President and CEO
Executive Director
|
2,055
-0.3%
152.81
USD 314,025
|
2,055
-0.3%
|
152.81
|
USD 314,025
|
|
|
2021-09-01 |
2021-08-30 |
PS
Planned sale
|
Goddard Glenn
EVP, Chief Financial Officer
Officer
|
300
-100.0%
160.84
USD 48,252
|
300
-100.0%
|
160.84
|
USD 48,252
|
|
